Phase 2 Myasthenia Gravis, Generalized Clinical Trials
3 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–3 of 3 trials
Recruiting
Phase 2
A Phase 2 Study to Evaluate Povetacicept in Adults With Generalized Myasthenia Gravis
Myasthenia Gravis, Generalized
Vertex Pharmaceuticals Incorporated30 enrolled24 locationsNCT07501702
Recruiting
Phase 1Phase 2
Study of Aritinercept in Patients With Generalized Myasthenia Gravis
Myasthenia Gravis, Generalized
Aurinia Pharmaceuticals Inc.81 enrolled3 locationsNCT07596901
Recruiting
Phase 2
Efficacy and Safety of Tocilizumab in the Treatment of Generalized Myasthenia Gravis
Myasthenia Gravis, Generalized
Tang-Du Hospital64 enrolled6 locationsNCT05067348